Back to Private Advisor Group, LLC Private Advisor Group, LLC

WEWEK
21 quarters

Position history for Private Advisor Group, LLCPrivate Advisor Group, LLC's holdings in ZIOPHARM ONCOLOGY INC

As of its Q4 2023 13F, Private Advisor Group held 67,735 shares of WEK (Ziopharm Oncology), worth $4,789. Private Advisor Group's 13F filings listed WEK from Q1 2019 to Q4 2023, 20 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$278,000

Total Shares Change

-72,192

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$5.28
0
2023-Q4
Decreased
67,735
-29.4%
$4,7890.0%$5.28
0
2023-Q3
Decreased
95,897
-11.5%
$12,6390.0%$5.28
0
2023-Q2
Decreased
108,312
-2.9%
$48,7750.0%$5.28
0
2023-Q1
Decreased
111,574
-0.9%
$70,2920.0%$5.28
0
2022-Q4
Decreased
112,574
-5.7%
$56,0730.0%$5.28
0
2022-Q3
Decreased
119,374
-9.7%
$206,0000.0%$5.28
0
2022-Q2
Decreased
132,130
-45.4%
$163,0000.0%$5.28
0
2022-Q1
Increased
242,154
+3.7%
$158,0000.0%$5.28
23
2021-Q4
Decreased
233,504
-32.7%
$254,0000.0%$5.28
0
2021-Q3
Increased
347,167
+55.0%
$631,0000.0%$5.28
34
2021-Q2
Decreased
223,924
-19.3%
$591,0000.0%$5.28
0
2021-Q1
Increased
277,609
+5.1%
$1M0.0%$5.28
26
2020-Q4
Increased
264,214
+30.5%
$665,0000.0%$5.28
31
2020-Q3
Increased
202,441
+3.6%
$576,0000.0%$5.28
25
2020-Q2
Decreased
195,441
-2.4%
$641,0000.0%$5.28
0
2020-Q1
Increased
200,141
+0.2%
$490,0000.0%$5.28
24
2019-Q4
Increased
199,707
+0.7%
$942,0000.0%$5.28
25
2019-Q3
Increased
198,357
+108.6%
$865,0000.0%$5.28
40
2019-Q2
Increased
95,086
+31.7%
$554,0000.0%$5.28
31
2019-Q1
First report
72,192
-
$278,0000.0%$5.28
0

Other major holders of WEK: MSD Partners, L.P., MILLER VALUE PARTNERS, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used